Research Paper Volume 13, Issue 6 pp 8026—8039

mTOR inhibition improves mitochondria function/biogenesis and delays cardiovascular aging in kidney transplant recipients with chronic graft dysfunction

class="figure-viewer-img"

Figure 6. (A) Trolox equivalent antioxidant capacity (TEAC) levels in blood from patients treated with calcineurin inhibitor (CNi) or CNi + mTOR inhibitor (CNi+mTORi). (B) Glutathione peroxidase (GPx) activity in peripheral blood mononuclear cells (PBMC) from patients treated with CNi or CNi+mTORi. Statistical difference was assessed by unpaired student’s t-test.